Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02023476 · ClinicalTrials.gov registry record · NA
Neurologic Examination of Wide and Narrow Tourniquets
A NA study, sponsored by Medical University of Vienna.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT02023476: Completed NA study, sponsored by Medical University of Vienna.
NCT02023476 is a NA study that has completed, run by Medical University of Vienna. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02023476, a NA study, has completed, sponsored by Medical University of Vienna.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
Nerve injury is a serious potential complication associated with the clinical use of exsanguinating tourniquets in surgery. Recently, a novel narrow tourniquet has been proposed, with the claim that it may cause less compression of the nerves. We performed an in vivo comparison of a standard wide tourniquet with the new, narrow tourniquet. Our study specifically looked at neurologic markers in the upper extremity.
Primary Outcome
mg/mm2
Interventions
- RADIATION MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2010-04 |
| Est. Completion | 2010-09 |
| Phase | NA |
What the finished NCT02023476 record still lists
NCT02023476 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which MRI is the first listed.
NCT02023476 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02023476 about?
NCT02023476 is a clinical study titled "Neurologic Examination of Wide and Narrow Tourniquets". Nerve injury is a serious potential complication associated with the clinical use of exsanguinating tourniquets in surgery. Recently, a novel narrow tourniquet has been proposed, with the claim that it may cause less compression of the nerves. We performed an in vivo comparison of a standard wide to...
What is the current status of trial NCT02023476?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2010-04. Estimated completion is 2010-09.
What interventions are being tested in trial NCT02023476?
The interventions under investigation include: MRI (RADIATION).
Who is sponsoring clinical trial NCT02023476?
This trial is sponsored by Medical University of Vienna, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02023476's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia